Arch Therapeutics Inc (ARTH)

[Regis999]

ARCH THERAPEUTICS (ARTH) DUE DILIGENCE ASSISTANCE

Dear Mom

How could a clear liquid be deemed a medical device??

A CLEAR LIQUID noncoagulant homostatic agent classified as a MEDICAL DEVICE. See You Tube Video Below–LIVER. Stops Bleeding in seconds……

See reason why this clear liquid is deemed a medical device in Europe human trials below also.

The CEO is a MD, MIT MBA and Former Portfolio Manager at Putnam $4 Billion Healthcare Fund.

The clear liquid medical device called AC5 is used to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. This is a most unusual medical device with vast impact on Surgery, Trauma Care, Wound Care (Pressure Ulcers, Foot Ulcers, Burns, etc), Military and other emergency situations. OVER 200 Potential APPLICATIONS. Human trials have begun in Ireland for this medical device Note MIT’s involvement.

The Company is Arch Therapeutics (Symbol ARTH)

Website WWW.ARCHTHERAPEUTICS.COM/



The Cheapest Medical Device Stock I’ve Ever Seen By Michael Murphy CFA

HTTP://SEEKINGALPHA.COM/ARTICLE/3286585-THE-CHEAPEST-MEDICAL-DEVICE-STOCK-IVE-EVER-SEEN

Arch Therapeutics has Initiated Human Clinical Trials in Europe–The Company has identified over 200 potential areas where AC5 could be used including: Surgery, Trauma Care, Wound Care, Military, Adhesions, Pressure Ulcers (Bedsores) (2.5 million cases in USA with annual cost $ 10 billion), Foot Ulcers, Burns, etc.

Presentation by Founder of AC5 Dr. Rutledge Ellis-Behnke PHD using AC5 on animals

AC5 Surgical HemostatTM is an Effective Hemostatic Agent in Anticoagulated Animals

You Tube Video

HTTPS://WWW.YOUTUBE.COM/WATCH?V=WWYHGYUSONQ&APP=DESKTOP

Dr. Rutledge Ellis-Behnke, PhD Linkedin BIO HTTPS://WWW.LINKEDIN.COM/IN/NANOMEDICINE

COMPANY Presentation (page 20 Foot ulcers-Pressure Ulcers, Burns)

HTTP://CONTENT.STOCKPR.COM/ARCHTHERAPEUTICS/MEDIA/A615BA3D0A9C00B0E77D846E84303000.PDF

Company Video HTTPS://WWW.YOUTUBE.COM/WATCH?V=-KUVC–OKFI

Arch Therapeutics, Inc. (Symbol ARTH)

Faster, Safer, Simpler Surgery

Arch is a small public company with a medical device pathway, relatively low capital requirements and potentially high margin novel products targeting large growing markets. Expect first product approval in 2016.

Arch Medical Device: A LIQUID noncoagulant homostatic agent known as “AC5.” Works in presence of “blood thinners.” Only one that does.

Scientists at Massachusetts Institute of Technology invented this universal fix-all hemostat that works in a few seconds.

AC5 is used to stop bleeding (hemostasis) and control leaking (sealant). Spray AC5 on a bleeding artery and the bleeding stops without mechanical pressure being needed in seconds.

Elevator Summary of Company HTTP://WWW.ARCHTHERAPEUTICS.BLOGSPOT.COM/

The Company’s product, AC5, a liquid peptide, should result in faster, safer, simpler surgery with substantial savings in time of surgery (some have estimated potentially up to 60%).

Anytime a hole in the body occurs one needs to worry about bleeding, leaking and contamination to mitigate infection. Arch’s AC5 to address these needs. Arch intends to transform the landscape of interventional healthcare with products to seal and protect leaking and bleeding tissue.

Human Clinical Trials have begun in Ireland. Total Europe and USA human trial cost estimated to be $8 to $12 million. Tiny in Biotech world.

The CEO is a MD, MIT MBA and Former Portfolio Manager at Putnam $4 Billion Healthcare Fund

Arch Therapuetic AC5 Surgical Hemostatic Device

Attributes of AC5

Synthetic peptide

Clear liquid, squirted or sprayed– Can see and operate through it

Conforms to irregular wound geometry
Physical mechanical barrier (no metabolic activity or chemical activity with the body)

Classified as Medical Device in Europe because of no interaction with the body
No sign of interaction with human cell receptors or cell kinase enzymes

Stops bleeding promptly

Faster time to stop bleeding versus five different popular marketed products

Blood thinner agnostic—only hemostasis product that is.

Efficacy even in presence of “blood thinners”
Bioasborbable

Natural amino acids, non-animal

Enables normal healing

Non-cytotoxic, non-pyrogenic, non-irritant, non-sensitizer

Stores at room temperature

Indefinite shelf life

Simple, effective, versatile, safe universal

There are many other hemostatic agents, but:

* They all rely on using the patient’s blood,

*They all take minutes to stop bleeding, not seconds

* None of them create a clear seal that a surgeon can see through

* None of them work just as well on people on blood thinners

* None of them work in every situation where bleeding has to be stopped

Arch’s AC5 product solves all these problems.

Please do you own due diligence.

Love,
REG